Growth Hormone Treatment Unknown Status Phase 2 Trials for Somatotropin (DB00052)

IndicationStatusPhase
DBCOND0043256 (Growth Hormone Treatment)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02326610
Early hGH Treatment of SGA Infants to Prevent Irreversible Neurologic and Psychological Damage and SequelaeTreatment